Lumida
/MRCY
⌘K
Mercury Systems Inc

Mercury Systems Inc

MRCY
$96.08USD+0.08%+0.08 today

MARKET CAP

5.8B

P/E (TTM)

82.8x

FWD P/E

61.2x

DAY RANGE

$92 – $99

52W RANGE

$50
$128

AI Summary

Stalk
TrimMedium

MRCY remains in a Stage 4 decline with active bearish patterns confirming supply dominance. Price trades below declining 9 EMA, 21 EMA, and 50 SMA, and while oversold conditions reduce urgency, sell-side execution should be deferred to shallow relief rallies into those moving averages. The long-term uptrend remains intact structurally but does not alter the medium-term bearish posture.

  • Q3 revenue rose 11.5% YoY to $235.8M with record $348.3M bookings (1.48 book-to-bill).
  • Backlog reached $1.6B (up 17.9% YoY), underpinning near-term revenue visibility.
  • Negative earnings yield and weak profitability factors signal margin concerns.
Full analysis →

The case for & against

Bull & Bear analysis

Bullish

Mercury Systems, Inc. (NASDAQ: MRCY) is a leader in the aerospace and defense sector, focusing on advanced processing solutions tailored for missile defense, command, control, communications, intelligence, surveillance, and reconnaissance (C4ISR) applications. The company is strategically positioned within a growing defense expenditure environment, benefiting from increased government spending on defense technologies.

Bull says

  • Q3 revenue rose 11.5% YoY to $235.8M with record $348.3M bookings (1.48 book-to-bill).
  • Backlog reached $1.6B (up 17.9% YoY), underpinning near-term revenue visibility.
  • Management expects margin expansion as transition to higher-margin projects continues.
  • Global defense budget increases boost demand for advanced C4ISR solutions.
  • $15M share buyback enhances shareholder value amid $332M cash reserves.
  • Strong growth factors and positive momentum favor potential stock upside.

Bear says

  • Negative earnings yield and weak profitability factors signal margin concerns.
  • Low-margin backlog still substantial, delaying expected EBITDA margin recovery.
  • Q3 free cash flow was a $1.8M outflow despite higher revenues.
  • High stock volatility and balance sheet weaknesses elevate downside risk.
  • Analyst forecasts suggest potential decline to ~$74.7 by end-2026.
  • Limited dividend returns and uncertain cash conversion may dampen returns.

Investment themes with MRCY

Defense -0.89%

Military equipment and defense contractors

BWXT · RKLB · CRS
Defense Tech -0.44%

LMT · RTX · GD
Drones -2.03%

Unmanned aerial vehicles and related technology

AVAV · ONDS · RCAT

Earnings Call · Q3 2025 · Mgmt. Guidance

Updated 06-14-2026neutral

Transcript signals

Bull points

  • We feel great about our position, feel really good about our pipeline, the activity in Q4, and, you know, all in all, good about the bookings performance in Q3.
  • we expect it to continue moving in that direction, but we haven't, we haven't broken out for, uh, in our financials exactly how much of the revenue is production versus development. But definitely, you should look at the bookings as an indicator.
  • we feel very good about that. It's an area where we see demand. We have differentiation. We added to the differentiation this quarter with the acquisition of Starlab, so we're feeling really good about the progression associated with CPA.

Bear points

  • every quarter that we're making more progress as we as we both finish off or get to the lower levels on some of the lower margin activities, and we're adding to our backlog, you know, at higher margins. So that backlog margin is increasing, and we expect to see that start playing out. As I said earlier, it'll play out over time. But, you know, we do expect to see benefit from both of those things in the fourth quarter to benefit the EBITDA.
  • the timing for that aggregate backlog to burn off and the number of quarters it would take for it to be replaced by the bookings that, since we made that comment, have been in line with what we expect to be our targeted margin profile associated with the EBITDA margin profile we've discussed of low to mid 20s so i think you can you know create an estimate for what that time frame looks like based on our duration and the commentary at the end of fy 24.
  • Although we are encouraged that our recent quarter bookings are accretive to our overall backlog margin, we continue to expect low double digit adjusted EBITDA margins overall for FY25.
Read full transcript analysis ›